B3GAT1 and breast cancer: However, BC Patients had slightly higher numbers of the terminally differentiated, highly cytotoxic CD57+ NK cells (p.adj >0.05; Fig. 2h) that was independent of chemotherapy/CDKi treatment (Supplementary Fig. 3g).